RecruitingNot ApplicableNCT06624826

Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality

Difference in Visual Performance of a Refractive Extended Depth of Focus Intraocular Lens in an Emmetropic or Monovision Modality


Sponsor

Prim. Prof. Dr. Oliver Findl, MBA

Enrollment

60 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Comparison of the visual performance of a refractive extended depth of focus intraocular lens in an emmetropic or monovision modality


Eligibility

Min Age: 21 YearsMax Age: 105 Years

Inclusion Criteria6

  • Age-related bilateral cataract
  • Age 21 or older
  • Visual acuity \> 0.05
  • Axial length: 21.00-27.00mm
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant
  • Written informed consent prior to surgery

Exclusion Criteria6

  • Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.) precluding good post-operative visual acuity
  • Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX)
  • Irregular astigmatism on corneal tomography
  • Pronounced dry eye disease
  • Previous ocular surgery or trauma
  • Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEmmetropic modality

PureSee IOL, emmetropic modality

DEVICEMonovision modality

PureSee IOL, monovision modality


Locations(1)

Vienna Institute for Research in Ocular Surgery

Vienna, Austria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624826


Related Trials